A class of signaling molecules, specifically short chains of amino acids, that are administered or endogenously active to increase the expression or activity of Brain-Derived Neurotrophic Factor (BDNF). BDNF is a crucial protein that supports the survival of existing neurons and encourages the growth and differentiation of new neurons and synapses. These peptides are investigated for their potential to enhance neuroplasticity and cognitive function.
Origin
The term combines the acronym ‘BDNF’ (Brain-Derived Neurotrophic Factor), ‘Upregulation’ (the increase in the number of receptors or the rate of a process), and ‘Peptides’ (short protein fragments). This concept originates from the neurobiology and pharmacology fields. The focus is on therapeutic strategies to counteract neurodegeneration and cognitive decline.
Mechanism
These peptides typically act by binding to specific receptors on neuronal and glial cells, initiating intracellular signaling cascades that lead to increased transcription of the BDNF gene. This results in greater production and release of the BDNF protein, which then binds to the TrkB receptor to promote neuronal survival, synaptic plasticity, and dendritic branching. The net effect is a biologically supported enhancement of neural network function and resilience.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.